Potential Role of GST‐π in Lung Cancer Stem Cell Cisplatin Resistance
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Abstract
Background. Cancer stem cells (CSCs) are responsible for tumorigenesis, chemoresistance, and metastasis. Chemoresistance is a major challenge in the management of lung cancer. Glutathione‐sulphur‐transferase‐π (GST‐π) plays an important role in the origin and development of various types of cancer by regulating the cellular redox balance. Recent investigations have demonstrated that GST‐π is associated with the chemoresistance of lung CSCs (LCSCs). However, the mechanism of GST‐π in lung cancer, particularly in LCSCs, remains unclear. The present study is aimed at exploring the potential role of GST‐π in stemness and cisplatin (DDP) resistance of LCSCs. Materials and methods. In the present study, lung cancer cell spheres were established using the A549 cell line, which according to our previous research, was confirmed to exhibit characteristics of stem cells. Next, GST‐π protein expression, apoptosis percentage, and intracellular reactive oxygen species (ROS) concentration in A549 adherent cells and A549 cell spheres were analyzed by western blotting and flow cytometry, respectively. Finally, DDP resistance, ROS concentration, and GST‐π expression in LCSCs were analyzed following the interference with GST‐π using DL‐buthionine‐(S,R)‐sulphoximine and N‐acetylcysteine. Results. The results revealed that GST‐π was highly expressed in A549 cell spheres compared with A549 adherent cells and was associated with a decreased intracellular ROS concentration (both P < 0.05). Regulating GST‐π protein expression could alter DDP resistance of LCSCs by influencing ROS. Conclusion. These results suggested that GST‐π may be important for LCSC drug resistance by downregulating ROS levels. These findings may contribute to the development of new adjuvant therapeutic strategies for lung cancer.Keywords
Funding Information
- Natural Science Foundation of Jiangxi Province (20202ACBL206019, 20171BAB205053)
This publication has 33 references indexed in Scilit:
- Antioxidants Accelerate Lung Cancer Progression in MiceScience Translational Medicine, 2014
- ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitorsBiochemical Journal, 2013
- Multidrug Resistance in Primary Tumors and Metastases in Patients with Esophageal Squamous Cell CarcinomaPathology and Oncology Research, 2013
- Enhancement of Carboplatin-Mediated Lung Cancer Cell Killing by Simultaneous Disruption of Glutathione and Thioredoxin MetabolismClinical Cancer Research, 2011
- Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell linesOncology Reports, 2011
- Mitochondrial and energy metabolism‐related properties as novel indicators of lung cancer stem cellsInternational Journal of Cancer, 2011
- Heterogeneity of Mitochondrial Membrane Potential: A Novel Tool to Isolate and Identify Cancer Stem Cells from a Tumor Mass?Stem Cell Reviews and Reports, 2010
- The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathioneInternational Journal of Molecular Medicine, 2010
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- The Essential Role of the Mitochondria and Reactive Oxygen Species in Cisplatin-Mediated Enhancement of Fas Ligand-Induced Apoptosis in Malignant Pleural MesotheliomaJournal of Surgical Research, 2007